Molecular and functional characterization of a human frataxin mutation found in hypertrophic cardiomyopathy
- 1 August 2005
- journal article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 85 (4) , 280-285
- https://doi.org/10.1016/j.ymgme.2005.04.010
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathyJournal of the American College of Cardiology, 2004
- Clinical Presentations of Mitochondrial CardiomyopathiesPediatric Cardiology, 2004
- Friedreich ataxiaSeminars in Pediatric Neurology, 2003
- Hypertrophic cardiomyopathy: two homozygous cases with “typical” hypertrophic cardiomyopathy and three new mutations in cases with progression to dilated cardiomyopathyBiochemical and Biophysical Research Communications, 2003
- Friedreich’s ataxiaPediatric Neurology, 2003
- Frataxin and frataxin deficiency in Friedreich's ataxiaJournal of the Neurological Sciences, 2003
- A novel TPM1 mutation in a family with hypertrophic cardiomyopathy and sudden cardiac death in childhoodThe American Journal of Cardiology, 2002
- Myosin Light Chain Mutation Causes Autosomal Recessive Cardiomyopathy With Mid-Cavitary Hypertrophy and Restrictive PhysiologyCirculation, 2002
- Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathyThe Lancet, 2000
- Prevalence of Hypertrophic Cardiomyopathy in a General Population of Young AdultsCirculation, 1995